• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec15
arGEN-X SE Halts Phase III Clinical Trial of Efgartigimod for Thyroid Eye Disease
06:00
Dec5
Morgan Stanley Raises Argenx Price Target to $1,110
15:41
Nov18
Argenx SE's Compensation Policy Approved by Extraordinary General Meeting
22:36
Argenx Shares Reach New 52-Week High, Citi Raises Price Target
06:49
Nov8
JPMorgan Raises Argenx Price Target to $925
21:26
Nov7
Argenx Reaches 52-Week High and Receives Analysts' Target Price Increase
20:21

Schedules & Filings

Schedules
Filings
Oct30
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.151 B, Net Income 344.26 M, EPS 5.18

Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 967.19 M, Net Income 245.36 M, EPS 3.7403

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 807.37 M, Net Income 169.47 M, EPS 2.58

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
AMCI
7.270
+168.27%
+4.560
RADX
10.630
+149.53%
+6.370
ARTV
6.300
+90.91%
+3.000
NTCL
0.9500
+39.71%
+0.270
MASK
0.4100
+36.35%
+0.109
QIPT
3.500
+34.10%
+0.890
KXIN
4.440
+33.73%
+1.120
ASTI
4.170
+33.65%
+1.050
CLIK
7.200
+28.34%
+1.590
CLYM
3.810
+27.00%
+0.810
View More